The Pfizer Clinical Research Unit in New Haven is conducting a clinical trial of an injectable study drug for obesity. This study will look at the effects of multiple doses of the study drug when given as subcutaneous injections (beneath the skin).
Obesity is a chronic weight condition that increases the potential risk of other illnesses such as stroke and diabetes. By 2030, it is projected that over a billion people worldwide will be considered obese.
While the scientific and medical community defines obesity as a complex, multifactorial disease requiring prevention and treatment efforts, there is still stigma associated with this condition that impacts patients’ quality of life and access to care. Most people with obesity do not receive any treatment, and diet and lifestyle changes are often not effective or accessible for everyone. Research into additional medication options is therefore essential for patients’ long-term well-being.
Learn how you can make a difference as a trial volunteer.
Who may participate
Your choice to join a clinical trial is always your own. We appreciate you considering this trial and are available to answer any questions you may have.
This study is seeking healthy adult volunteers that are either overweight or obese, meaning that the participants meet certain BMI criteria but are otherwise in stable health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to receive injections of the study drug beneath the skin
- Willing and able to come to our facility in New Haven, CT for all scheduled overnights and study visits*
- Willing and able to self-administer injections at home (with instruction from study staff)
- Current BMI between 25 and 40
*participants may be eligible to receive a bonus for study travel, ask our staff for details
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Healthy
Age
18-70 years
Sex
All sexes
Referral bonus
Up to $200
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will complete a combination of inpatient and outpatient visits. Participation includes:
- 4 separate stays at the PCRU (a.k.a. admissions) of 8 overnights each (32 nights total)
- 10 outpatient (no overnight) visits, including follow-up
- 4 total doses of study drug, given as injections beneath the skin
You can access the full schedule for this study at the link below, and it will also be shared and reviewed during your screening appointment. We ask you to check this schedule carefully to be sure that all dates work for you and to let staff know if you have any concerns ahead of time.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
This study requires you to stay at the PCRU for the entire duration of each inpatient stay unless you choose to withdraw. You can learn more about what to expect during your participation by browsing our FAQ section.
Required overnight stays
4 admissions of 8 nights each (32 total)
Long-term follow up
5 follow-up visits
How long is this study?
About 24 weeks
Compensation
Up to $23,400 upon completion of the study
All of the study procedures will be clearly explained to you during screening and can be viewed in the informed consent form.
We've updated the PCRU Loyalty Program!
We refreshed our Participant Loyalty Program with all-new unique tiered gifts for new and returning participants.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.